المؤلفون: Simone Birnbaum, Benjamin Rohaut, Judith Mendelson, Francis Bolgert, R. Le Panse, Diane Friedman, Yasmine Domingo, Nicolas Weiss, Bernard Clair, Anthony Behin, Isabelle Ledoux, Frédérique Truffault, Nawal Derridj Ait-Younes, Mélinée Frenkian, Sandra Misdrahi, Guillaume Bassez, Cécilia Orblin Bedos, Jacques Ropers, Tarek Sharshar, B. Eymard, Pierre Portero, S Berrih-Aknin, Sophie Demeret, Philippe Aegerter, Sonia Berrih-Aknin, Estelle Louët, Linda William, Pascal Laforêt, Philippe Thoumie, Raphaël Porcher, Marcela Gargiulo, J.Y. Hogrel, Sylvie Azerad, Elodie Soler, Asmaa Jobic

المساهمون: Institute of Myology Paris France

المصدر: Neuromuscular Disorders
Neuromuscular Disorders, Elsevier, 2021, 31 (8), pp.726-735. ⟨10.1016/j.nmd.2021.05.002⟩

مصطلحات موضوعية: Adult, Male, Quality of life, medicine.medical_specialty, Randomization, Exacerbation, [SDV]Life Sciences [q-bio], Rowing, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Autoimmune disease, Clinical endpoint, Humans, Medicine, Prospective Studies, Home based exercise, Myasthenia gravis, Exercise, Genetics (clinical), Aged, Exercise Tolerance, business.industry, Middle Aged, medicine.disease, Exercise Therapy, 3. Good health, Neurology, 030220 oncology & carcinogenesis, Pediatrics, Perinatology and Child Health, Physical therapy, Female, Neurology (clinical), business, 030217 neurology & neurosurgery

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8cd47068b252db3dfb3e52a6d4cec5a
https://hal.archives-ouvertes.fr/hal-03442076

المؤلفون: Sandrine Hayette, Tibor Kovacsovics, Jean-Michel Cayuela, Elizabeth Macintyre, Amel Ouslimani, Eric Delabesse, Hervé Dombret, Jean Gabert, Claude Preudhomme, André Delannoy, Jean-Paul Vernant, Francoise Huguet-Rigal, Anne Vekhoff, Norbert Vey, Francis Witz, Charles Dauriac, Elodie Soler, Stéphane de Botton, Xavier Thomas

المصدر: ResearcherID
Publons

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Mitoxantrone, business.industry, Immunology, Imatinib, Cell Biology, Hematology, Biochemistry, Minimal residual disease, Chemotherapy regimen, Surgery, Transplantation, Regimen, Imatinib mesylate, hemic and lymphatic diseases, Internal medicine, medicine, Autologous transplantation, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e2f4f93f0db51ef5eb438f2aef26bbc
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000225127502742&KeyUID=WOS:000225127502742